First Horizon Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
213,224
+1,829
+0.9% +$105K 0.47% 67
2026
Q1
$12.8M Buy
211,395
+89,074
+73% +$5.19M 0.54% 61
2025
Q4
$6.6M Sell
122,321
-25,288
-17% -$1.22M 0.29% 96
2025
Q3
$6.66M Buy
+147,609
New +$6.89M 0.31% 97
2021
Q2
$4.3M Buy
64,428
+166
+0.3% +$10.8K 0.39% 81
2021
Q1
$4.06M Buy
64,262
+2,037
+3% +$127K 0.39% 80
2020
Q4
$3.86M Buy
62,225
+59
+0.1% +$3.63K 0.38% 80
2020
Q3
$3.75M Buy
+62,166
New +$3.74M 0.4% 82
2013
Q2
$1.86M Buy
+41,521
New +$1.8M 0.51% 73

Other funds holding BMY

First Horizon Corporation's BMY Position: Q2 2026 in Review

First Horizon Corporation increased its Bristol-Myers Squibb (BMY) stake by 0.87% in Q2 2026, buying an estimated $105K and bringing the position to 213,224 shares worth $12.3M. The position accounts for 0.47% of the portfolio, ranked #67.

First Horizon Corporation first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. The position peaked at $12.8M in Q1 2026. 823 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First Horizon Corporation held 213,224 shares of Bristol-Myers Squibb worth $12.3M as of Q2 2026.
  • First Horizon Corporation bought 1,829 Bristol-Myers Squibb shares in Q2 2026, an estimated $105K.
  • Bristol-Myers Squibb made up 0.47% of First Horizon Corporation's portfolio in Q2 2026, its #67 holding.
  • First Horizon Corporation first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's Bristol-Myers Squibb position peaked at $12.8M in Q1 2026.
  • 823 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.